23 results
6-K
EX-99.1
GMAB
Genmab
15 Feb 24
Notice to Convene the Annual General Meeting of Genmab A/S
7:23pm
large organizations. She furthermore has significant experience with the development of governance and ESG responsibilities from various leadership … within accounting, her service in senior finance leadership at TDC Group A/S and as an audit committee chair or member at other public companies
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
Valby, Denmark
www.genmab.com
CVR no. 2102 3884
GENMAB 2023 ANNUAL REPORT
EXPERIENCED LEADERSHIP
We operate from a core set of values that underpins … of Directors continued to provide governance, guidance and dedicated leadership. Comprised of experts in their fields, the Board of Directors has
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
Sustainability Reporting Directive (CSRD) and the U.S. Securities and Exchange Commission’s Climate-Related Disclosures. Experienced Leadership We operate from … development since 2011. In 2023, our Board of Directors continued to provide governance, guidance and dedicated leadership. Comprised of experts
6-K
EX-99.1
py045i3 xna
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
70sgi1h
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
2o2l6mn3pqyzzm65ygk
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
4hzj6s6 2ntk043ir4t
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
bwcfbslwwog oypm
22 Feb 21
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
9:53am
6-K
EX-99.1
hkykd1a 3iwnx
10 Jun 20
Genmab and AbbVie Announce Broad Oncology Collaboration
7:33am
6-K
EX-99.1
aca0lawwklu y1r2nso
6 May 20
Genmab Announces Financial Results for the First Quarter of 2020
2:31pm
20-F
x6bqjd91gvesmvvuyi4q
30 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
5kflj g33ssyvdu
10 Mar 20
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
9:17am
6-K
EX-99.1
t6o07tp0d
21 Feb 20
Current report (foreign)
4:40pm
6-K
EX-99.1
zrmfpmpz0dmk4
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
6-K
EX-99.1
hk1cpartth fjr1l
30 Oct 19
Current report (foreign)
5:11pm
424B4
vug2 8xfj
19 Jul 19
Prospectus supplement with pricing info
12:00am
F-1
1ndd9d
28 May 19
Registration statement (foreign)
4:27pm